These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 8630659)

  • 21. Production of C-reactive protein and risk of coronary events in stable and unstable angina. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group.
    Haverkate F; Thompson SG; Pyke SD; Gallimore JR; Pepys MB
    Lancet; 1997 Feb; 349(9050):462-6. PubMed ID: 9040576
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Macrophage inflammatory protein-1β and fibrinogen are synergistic predictive markers of prognosis of intermediate coronary artery lesions.
    Xu F; Lv S; Chen Y; Song X; Jin Z; Yuan F; Zhou Y; Li H
    Cardiology; 2012; 121(1):12-9. PubMed ID: 22378071
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Unrecognized myocardial infarction: epidemiology, clinical characteristics, and the prognostic role of angina pectoris. The Reykjavik Study.
    Sigurdsson E; Thorgeirsson G; Sigvaldason H; Sigfusson N
    Ann Intern Med; 1995 Jan; 122(2):96-102. PubMed ID: 7993002
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lack of association between haemostatic variables and the presence or the extent of coronary atherosclerosis.
    Schmitz-Huebner U; Thompson SG; Balleisen L; Fechtrup C; Grosse-Heitmeyer W; Kirchhof B; Most E; Müller US; Seiffert C; Seiffert D
    Br Heart J; 1988 Mar; 59(3):287-91. PubMed ID: 3258521
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of C-reactive protein and fibrinogen on cardiovascular prognosis in patients with stable angina pectoris: the AtheroGene study.
    Sinning JM; Bickel C; Messow CM; Schnabel R; Lubos E; Rupprecht HJ; Espinola-Klein C; Lackner KJ; Tiret L; Münzel T; Blankenberg S;
    Eur Heart J; 2006 Dec; 27(24):2962-8. PubMed ID: 17132649
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ECAT angina pectoris study: baseline associations of haemostatic factors with extent of coronary arteriosclerosis and other coronary risk factors in 3000 patients with angina pectoris undergoing coronary angiography.
    Eur Heart J; 1993 Jan; 14(1):8-17. PubMed ID: 8432297
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma fibrinogen level and long-term prognosis in Norwegian middle-aged patients with previous myocardial infarction. A 10 year follow-up study.
    Retterstol L; Kierulf P; Pedersen JC; Bohn M; Bakken A; Erikssen J; Berg K
    J Intern Med; 2001 Jun; 249(6):511-8. PubMed ID: 11422657
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical and prognostic implications of angina pectoris developing during dobutamine stress echocardiography in the absence of inducible wall motion abnormalities.
    Elhendy A; Biagini E; Schinkel AF; van Domburg RT; Bax JJ; Rizzello V; Roelandt JR; Poldermans D
    Am J Cardiol; 2005 Sep; 96(6):788-93. PubMed ID: 16169362
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic value of I-123 metaiodobenzylguanidine imaging in vasospastic angina without significant coronary stenosis.
    Sakata K; Iida K; Kudo M; Yoshida H; Doi O
    Circ J; 2005 Feb; 69(2):171-6. PubMed ID: 15671608
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The influence of coronary angiography and angioplasty on parameters of hemostasis and fibrinolysis.
    Six AJ; Tjon RM; Buys EM; Haas F; Hollander-van Zalk A; Haverkate F
    Thromb Haemost; 1990 Aug; 64(1):113-6. PubMed ID: 2148844
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alterations of coagulation and fibrinolytic and kallikrein-kinin systems in the acute and postacute phases in patients with unstable angina pectoris.
    Hoffmeister HM; Jur M; Wendel HP; Heller W; Seipel L
    Circulation; 1995 May; 91(10):2520-7. PubMed ID: 7743613
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antithrombotic treatment (argatroban vs. heparin) in coronary angioplasty in angina pectoris: effects on inflammatory, hemostatic, and endothelium-derived parameters.
    Suzuki S; Matsuo T; Kobayashi H; Matsuo M; Shimamo C; Koide M; Sakamoto S
    Thromb Res; 2000 May; 98(4):269-79. PubMed ID: 10822073
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Short-, medium-, and long-term follow-up after percutaneous transluminal coronary angioplasty for stable and unstable angina pectoris.
    Kamp O; Beatt KJ; De Feyter PJ; van den Brand M; Suryapranata H; Luijten HE; Serruys PW
    Am Heart J; 1989 May; 117(5):991-6. PubMed ID: 2523638
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changes of hemostasis, endogenous fibrinolysis, platelet activation and endothelins after percutaneous transluminal coronary angioplasty in patients with stable angina.
    Borries M; Heins M; Fischer Y; Stiegler H; Peters A; Reinauer H; Schoebel FC; Strauer BE; Leschke M
    J Am Coll Cardiol; 1999 Aug; 34(2):486-93. PubMed ID: 10440163
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Variability over time of haemostatic and other cardiovascular risk factors in patients suffering from angina pectoris. ECAT Angina Pectoris Study Group.
    Pyke SD; Thompson SG; Buchwalsky R; Kienast J
    Thromb Haemost; 1993 Nov; 70(5):743-6. PubMed ID: 8128428
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ischemia during ambulatory monitoring as a prognostic indicator in patients with stable coronary artery disease.
    Mulcahy D; Husain S; Zalos G; Rehman A; Andrews NP; Schenke WH; Geller NL; Quyyumi AA
    JAMA; 1997 Jan 22-29; 277(4):318-24. PubMed ID: 9002495
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Troponin T in patients with low grade or atypical angina. Identification of a high risk group for short- and long-term cardiovascular events.
    Möckel M; Störk T; Heller G; Röcker L; Danne O; Darrelmann KG; Eichstädt H; Frei U
    Eur Heart J; 1998 Dec; 19(12):1802-7. PubMed ID: 9886722
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hemostatic risk factors of coronary artery disease in the Chinese.
    Ho CH; Wang SP; Jap TS
    Int J Cardiol; 1995 Aug; 51(1):79-84. PubMed ID: 8522401
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prothrombin activation fragment 1 + 2 and thrombin antithrombin III complexes in patients with angina pectoris: relation to the presence and severity of coronary atherosclerosis.
    Kienast J; Thompson SG; Raskino C; Pelzer H; Fechtrup C; Ostermann H; van de Loo J
    Thromb Haemost; 1993 Oct; 70(4):550-3. PubMed ID: 8115978
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased plasma factor VIII:c activity in patients with unstable angina pectoris.
    Olinic D; Brudaşcă I; Colhon D; Stoia M; Cucuianu M
    Rom J Intern Med; 1996; 34(1-2):65-71. PubMed ID: 8908632
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.